Category
102 releases
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a…
Preliminary, unaudited revenue range of approximately $24.5 to $26.5 million through September 30, 2026 already exceeds full-year 2025 revenue; AI…
The Western Pennsylvania independent RIA, with approximately $220 million in client assets, is the latest partner firm to join RFP CHICAGO, Oct. 26,…
Investment creates a platform to expand the delivery of high-quality, modular affordable housing across the United States LOUISVILLE, Ky., Oct. 26,…
Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, will release its financial results for the…
New name reflects the firm's heritage and continued focus on small buyout and growth investing BOSTON, Oct. 26, 2026 — BPEA Private Equity today…
Transaction adds commercial and contract surety expertise, nationwide reach and best-in-class platform for agents, brokers and customers PHOENIX and…
BANK OF MARIN BANCORP REPORTS THIRD QUARTER FINANCIAL RESULTS DRIVEN BY LOAN GROWTH, NIM EXPANSION AND HIGHER EARNINGS
First Resource Bancorp, Inc. (OTCQX: FRSB), reported strong financial performance for the third quarter ended September 30, 2026. Lauren C. Ranalli,…
FanEngine adds IP assets that build valuable, direct relationships with fans across global sports, music and entertainment franchises
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics…
Combination to establish a North American growth platform pairing Umios' global sourcing capabilities with High Liner Foods' processing expertise and…
MainStreet Bancshares, Inc. Reports Third Quarter 2026 Results
and Business Highlights
REPORTS THIRD QUARTER 2026 RESULTS
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered…
WuXi AppTec (Stock Codes: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing…
